论文信息 - SnapShot: COVID-19

SnapShot: COVID-19

Abstract Coronavirus disease 2019 (COVID-19) is a novel respiratory illness caused by SARS-CoV-2. Viral entry is mediated through viral spike protein and host ACE2 enzyme interaction. Most cases are mild; severe disease often involves cytokine storm and organ failure. Therapeutics including antivirals, immunomodulators, and vaccines are in development. To view this SnapShot, open or download the PDF.

[1] J. Hageman. The Coronavirus Disease 2019 (COVID-19). , 2020, Pediatric annals.

[2] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[3] Alfonso J. Rodriguez-Morales,et al. Coronavirus Disease 2019–COVID-19 , 2020, Clinical Microbiology Reviews.

[4] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[5] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[6] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[7] Y. Teo,et al. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review , 2020, Journal of clinical medicine.

[8] E. Holmes,et al. The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.

[9] Jason M Pogue,et al. Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options , 2020, Open forum infectious diseases.

[10] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[11] T. Palaga,et al. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. , 2020, Asian Pacific journal of allergy and immunology.